Abstract:Objective To investigate the relationship between CD56+ derived IFN-γ expression and the prognosis in patients with cervical cancer.Methods The enrolled participants were 121 patients with cervicitis,cervical precancerous lesions or cervical cancer confirmed by colposcopy biopsy or gynecological surgery in Tangshan Workers' Hospital from February 2008 to November 2011,including 25 with chronic cervicitis (control group),l 1 with cervical intraepithelial neoplasia (CIN) grade Ⅰ (CIN Ⅰ group),45 with CIN grade Ⅱ/Ⅲ (CIN Ⅱ/Ⅲ group),and 40 with squamous carcinoma of the cervix (SCC) (SCC group).We used double-immunofluorescent staining to quantify CD56+ (NK cell specific marker) and CD56+ IFN-γ+ cells in the cervical tissues.The prevalence of HPV16 infection,HPV18 infection and infection with other 12 high-risk types of HPV in the cervical tissues were detected pathologically.Expression of IFN-γ mRNA in the above cervical tissues was measured by qRT-PCR.The SCC group was divided into high-level expression and low-level expression based on the mean value of percentage of CD56+ IFN-γ + cells in the SCC group.All the patients in the SCC group were followed up.Univariate analysis of the survival rate was based on the Kaplan-Meier survival curve,and Log-rank test was used to compare the survival distributions.Multivariate analysis of the survival rate was performed by using the Cox's proportional hazards models.Results The percentage of CD56+ cells and CD56+ IFN-γ + cells differed significantly among the 4 groups (P ＜ 0.05).Compared with the control group,the percentage of CD56+ cells in cervical tissues of CIN Ⅰ group was significantly increased (P ＜ 0.05).Compared with the control and CIN Ⅰ group,the percentage of CD56+ cells increased while that of CD56+ IFN-γ+ cells decreased significantly in cervical tissues of CIN Ⅱ/Ⅲ and SCC group (P ＜ 0.05).Compared with CIN Ⅱ/Ⅲ group,both the percentages of CD56+ cells and CD56+IFN-γ + cells decreased significantly in the cervical tissues of SCC group (P ＜ 0.05).The prevalence of HPV16 infection in the cervical tissues differed obviously among the 4 groups (P ＜ 0.05),but that of HPV18 infection and other 12 high-risk types of HPV infection did not (P ＞ 0.05).Lower expression of IFN-γ mRNA was found in those with HPV16 infection than those without in the control group (P ＜ 0.05).The expression of IFN-γ mRNA was not associated with HPV16 infection in patients in the CIN Ⅰ group (P ＞0.05).Higher expression of IFN-γ mRNA was found in those with HPV16 infection than those without in both the CIN Ⅱ/Ⅲ group and SCC group (P ＜ 0.05).Clinical parameters of lymph node metastasis and FIGO staging were associated with the CD56+IFN-γ+ expression in SCC group (P ＜ 0.05).During the follow-up period,11 (27.5％) of the 40 SCC cases died,the other 29 (72.5％) survived.Patients in high-level expression of CD56+ IFN-γ+ had higher survival rate than those in the low-level expression of CD56+ IFN-γ+ (92.86％ vs.61.54％,x2 =4.405,P =0.036).The Cox regressron analysis showed that,expression of CD56+IFN-γ+ was associated with the prognosis of patients in SCC group [HR =2.592,95％ CI (1.171,4.013),P ＜ 0.05].Conclusion The expression of CD56+ cells significantly increase with the progression of cervical lesions,but the expression of CD56+ IFN-γ+ significantly decline,which may be associated with the prognosis in SCC patients.

Expression of cyclinD1 and nm23 in the locally advanced cervical cancer after neoadjuvant chemotherapy and its significance

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Effects of Core Needle Biopsy and Subsequent Neoadjuvant Chemotherapy on Molecular Alterations and Outcome in Breast Cancer

Relation of NM23-H1 and CD44v6 Expression to Patient's Prognosis in the Non-Small Cell Lung Cancer Without Lymph Node Metastasis

Tumor-infiltrating CD8+ and FOXP3+ Lymphocytes Before and after Neoadjuvant Chemotherapy in Cervical Cancer

Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer

CCND1 As a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

Relationship between CD56+-derived IFN-γ Expression and the Prognosis in Cervical Cancer

The Relation Between the Expression of Nm23-H1,pcna and the Metastasis of Cervical Carcinoma

Relationship Between ERCC1,XPC Proteins and Curative Effect of Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancers

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Therapeutic effect of neoadjuvant chemotherapy on local advanced cervical carcinoma

Effect of nm23 gene expression on the survival and other prognostic indexes of patients with breast cancer

Prognostic Value and Clinicopathologic Significance of Nm23 in Various Cancers: A Systematic Review and Meta-Analysis

Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer

Relationship Between Mrna Expression of Metastasis Suppressor Gene Nm23 and Clinicopathological Features and Prognosis of Non Small Cell Lung Carcinoma

[HER-2 Expression in Local Advanced Breast Cancer and the Efficacy of Neoadjuvant Chemotherapy Regimens].

Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?

Study on significance of LPT,colposcopy and expression of C-erbB2 and nm23-H1 in early diagnosis of cervical carcinomal

Prognostic and Clinicopathological Significance of Nm23-H1 Expression in Non-Small Cell Lung Cancer: A Meta-Analysis

Effect of Neoadjuvant Chemotherapy in Treatment of Locally Advanced Breast Cancer with Cytologically Proven Axillary Node Metastases